1. GWAS of multiple neuropathology endophenotypes identifies new risk loci and provides insights into the genetic risk of dementia
- Author
-
Shade, Lincoln M. P., Katsumata, Yuriko, Abner, Erin L., Aung, Khine Zin, Claas, Steven A., Qiao, Qi, Heberle, Bernardo Aguzzoli, Brandon, J. Anthony, Page, Madeline L., Hohman, Timothy J., Mukherjee, Shubhabrata, Mayeux, Richard P., Farrer, Lindsay A., Schellenberg, Gerard D., Haines, Jonathan L., Kukull, Walter A., Nho, Kwangsik, Saykin, Andrew J., Bennett, David A., Schneider, Julie A., Ebbert, Mark T. W., Nelson, Peter T., and Fardo, David W.
- Abstract
Genome-wide association studies (GWAS) have identified >80 Alzheimer’s disease and related dementias (ADRD)-associated genetic loci. However, the clinical outcomes used in most previous studies belie the complex nature of underlying neuropathologies. Here we performed GWAS on 11 ADRD-related neuropathology endophenotypes with participants drawn from the following three sources: the National Alzheimer’s Coordinating Center, the Religious Orders Study and Rush Memory and Aging Project, and the Adult Changes in Thought study (n= 7,804 total autopsied participants). We identified eight independent significantly associated loci, of which four were new (COL4A1, PIK3R5, LZTS1and APOC2). Separately testing known ADRD loci, 19 loci were significantly associated with at least one neuropathology after false-discovery rate adjustment. Genetic colocalization analyses identified pleiotropic effects and quantitative trait loci. Methylation in the cerebral cortex at two sites near APOC2was associated with cerebral amyloid angiopathy. Studies that include neuropathology endophenotypes are an important step in understanding the mechanisms underlying genetic ADRD risk.
- Published
- 2024
- Full Text
- View/download PDF